A Pilot Study of Camrelizumab with Docetaxel and Cisplatin for the First Line Treatment in Recurrent/metastatic Oral Squamous Cell Carcinoma.
MEDCOMM（2023）
关键词
camrelizumab,first-line treatment,immunotherapy,oral cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要